Yıl: 2021 Cilt: 4 Sayı: 3 Sayfa Aralığı: 181 - 189 Metin Dili: İngilizce DOI: 10.30714/j-ebr.2021370072 İndeks Tarihi: 08-10-2021

Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients

Öz:
Aim: Fournier's gangrene (FG) is a rare, rapidly progressing and life-threatening disease of the genital, perianal and perineal regions. We aimed to evaluate etiological parameters, accompanying diseases, current treatment methods and factors affecting mortality in patients with FG. Method: The medical records of 38 patients who were operated by the same team with a diagnosis of FG from December 2015 to January 2021 were retrospectively reviewed. Those patients were divided into two groups: survivors (Group 1), and non-survivors (Group 2). Comparisons were made regarding clinical and demographic features; comorbid diseases; leukocyte count at first presentation; etiological factors; treatment outcomes; and mortality rates. Results: Thirty-eight patients (24 males, 14 females) were evaluated; mean age was 60.2 ± 13.2 years. While 76.3% (n = 29) of these patients recovered with treatment, the total mortality rate was 23.7% (n = 9). The most common cause of the FG and comorbidity were anorectal diseases (n = 22; 57.9%) and type 2 diabetes mellitus (n = 21; 55.3%), respectively. Female gender, septic shock, necrosis, abdominal wall and lumbar region involvement, chronic renal failure, FG development secondary to postoperative complications and ostomy rates were higher in non-survivors. There were no significant differences between the two groups regarding leukocyte count at first presentation, number of debridement, dressing methods, reconstruction methods, and length of hospital stay. Conclusions: Female gender, presence of septic shock and necrosis on physical examination, involvement of the abdominal wall and lumbar region in addition to the perianal region, chronic renal failure, disease secondary to postoperative complications and the necessity of ostomy play an important role in mortality.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1]Fournier JA. Jean-Alfred Fournier 1832- 1914. Gangrène foudroyante de la verge (overwhelming gangrene). Sem Med 1883. Diseases of the colon and rectum. 1988;31(12):984-88.
  • [2]Wilson B. Necrotizing fasciitis. The American surgeon. 1952;18(4):416-31.
  • [3]Morpurgo E, Galandiuk S. Fournier's gangrene. The Surgical clinics of North America. 2002;82(6):1213-24.
  • [4]Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions. Annales chirurgiae et gynaecologiae Supplementum. 2000(214):7-36.
  • [5]Eke N, Echem RC, Elenwo SN. Fournier's gangrene in Nigeria: a review of 21 consecutive patients. International surgery. 2000;85(1):77-81.
  • [6]Oguz A, Gümüş M, Turkoglu A, et al. Fournier's Gangrene: A Summary of 10 Years of Clinical Experience. International surgery. 2015;100(5):934-41.
  • [7]Hejase MJ, Simonin JE, Bihrle R, et al. Genital Fournier's gangrene: experience with 38 patients. Urology. 1996;47(5):734- 39.
  • [8]Benizri E, Fabiani P, Migliori G, et al. Gangrene of the perineum. Urology. 1996;47(6):935-39.
  • [9]Jeong HJ, Park SC, Seo IY, et al. Prognostic factors in Fournier gangrene. International journal of urology : official journal of the Japanese Urological Association. 2005;12(12):1041-44.
  • [10]Pour SM. Use of negative pressure wound therapy with silver base dressing for necrotizing fasciitis. Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society. 2011;38(4):449- 52.
  • [11]Vick R, Carson CC, 3rd. Fournier's disease. The Urologic clinics of North America. 1999;26(4):841-49.
  • [12]Sockkalingam VS, Subburayan E, Velu E, et al. Fournier's gangrene: prospective study of 34 patients in South Indian population and treatment strategies. Pan African medical journal. 2018;12(31):110.
  • [13]Bilton BD, Zibari GB, McMillan RW, et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. The American surgeon. 1998;64(5):397-400.
  • [14]Singh A, Ahmed K, Aydin A, et al. Fournier's gangrene. A clinical review. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 2016;88(3):157-64.
  • [15]Sorensen MD, Krieger JN, Rivara FP, et al. Fournier's gangrene: management and mortality predictors in a population based study. The Journal of urology. 2009;182(6):2742-47.
  • [16]Yeniyol CO, Suelozgen T, Arslan M, et al. Fournier's gangrene: experience with 25 patients and use of Fournier's gangrene severity index score. Urology. 2004;64(2):218-22.
  • [17]Smith GL, Bunker CB, Dinneen MD. Fournier's gangrene. British journal of urology. 1998;81(3):347-55.
  • [18]Czymek R, Frank P, Limmer S, et al. Fournier's gangrene: is the female gender a risk factor? Langenbecks Arch Surg. 2010;395(2):173-80.
  • [19]Shyam DC, Rapsang AG. Fournier's gangrene. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 2013;11(4):222-32.
  • [20]Ersay A, Yilmaz G, Akgun Y, et al. Factors affecting mortality of Fournier's gangrene: review of 70 patients. ANZ journal of surgery. 2007;77(1-2):43-48.
  • [21]Taviloglu K, Yanar H. Necrotizing fasciitis: strategies for diagnosis and management. World Journal of Emergency Surgery. 2007;2(1):19.
  • [22]Hahn HM, Jeong KS, Park DH, et al. Analysis of prognostic factors affecting poor outcomes in 41 cases of Fournier gangrene. Annals of surgical treatment and research. 2018;95(6):324-32.
  • [23]Enriquez JM, Moreno S, Devesa M, et al. Fournier's syndrome of urogenital and anorectal origin. A retrospective, comparative study. Diseases of the colon and rectum. 1987;30(1):33-37.
  • [24]Kumar D, Cortés-Penfield NW, El-Haddad H, et al. Bowel Perforation Resulting in Necrotizing Soft-Tissue Infection of the Abdomen, Flank, and Lower Extremities. Surgical infections. 2018;19(5):467-72.
  • [25]Villanueva-Sáenz E, Martínez HernándezMagro P, Valdés Ovalle M, et al. Experience in management of Fournier's gangrene. Techniques in coloproctology. 2002;6(1):5- 10.
  • [26]Norton KS, Johnson LW, Perry T, et al. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. The American surgeon. 2002;68(8):709-13.
  • [27]Ozturk E, Ozguc H, Yilmazlar T. The use of vacuum assisted closure therapy in the management of Fournier's Gangrene. American journal of surgery. 2009;197(5):660-65.
  • [28]Arslan E, Ozturk OG, Aksoy A, et al. Vacuum-assisted closure therapy leads to an increase in plasma fibronectin level. International wound journal. 2011;8(3):224- 28.
  • [29]Assenza M, Cozza V, Sacco E, et al. VAC (Vacuum Assisted Closure) treatment in Fournier's gangrene: personal experience and literature review. La Clinica terapeutica. 2011;162(1):e1-5.
  • [30]Czymek R, Schmidt A, Eckmann C, et al. Fournier's gangrene: vacuum-assisted closure versus conventional dressings. American journal of surgery. 2009;197(2):168-76.
  • [31]Ozkan OF, Altýnlý E, Koksal N, et al. Combining Flexi-Seal and negative pressure wound therapy for wound management in Fournier's gangrene. International wound journal. 2015;12(3):364-5.
  • [32]Ozkan OF, Koksal N, Altinli E, et al. Fournier's gangrene current approaches. International wound journal. 2016;13(5):713-16.
  • [33]Insua-Pereira I, Ferreira PC, Teixeira S, et al. Fournier's gangrene: a review of reconstructive options. Central European journal of urology. 2020;73(1):74-79.
APA derebey m, tarım i, Karabacak U, Şeker K, Özbalcı G (2021). Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. , 181 - 189. 10.30714/j-ebr.2021370072
Chicago derebey murat,tarım ismail alper,Karabacak Ufuk,Şeker Kadir,Özbalcı Gökhan Selçuk Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. (2021): 181 - 189. 10.30714/j-ebr.2021370072
MLA derebey murat,tarım ismail alper,Karabacak Ufuk,Şeker Kadir,Özbalcı Gökhan Selçuk Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. , 2021, ss.181 - 189. 10.30714/j-ebr.2021370072
AMA derebey m,tarım i,Karabacak U,Şeker K,Özbalcı G Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. . 2021; 181 - 189. 10.30714/j-ebr.2021370072
Vancouver derebey m,tarım i,Karabacak U,Şeker K,Özbalcı G Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. . 2021; 181 - 189. 10.30714/j-ebr.2021370072
IEEE derebey m,tarım i,Karabacak U,Şeker K,Özbalcı G "Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients." , ss.181 - 189, 2021. 10.30714/j-ebr.2021370072
ISNAD derebey, murat vd. "Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients". (2021), 181-189. https://doi.org/10.30714/j-ebr.2021370072
APA derebey m, tarım i, Karabacak U, Şeker K, Özbalcı G (2021). Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. Experimental Biomedical Research, 4(3), 181 - 189. 10.30714/j-ebr.2021370072
Chicago derebey murat,tarım ismail alper,Karabacak Ufuk,Şeker Kadir,Özbalcı Gökhan Selçuk Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. Experimental Biomedical Research 4, no.3 (2021): 181 - 189. 10.30714/j-ebr.2021370072
MLA derebey murat,tarım ismail alper,Karabacak Ufuk,Şeker Kadir,Özbalcı Gökhan Selçuk Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. Experimental Biomedical Research, vol.4, no.3, 2021, ss.181 - 189. 10.30714/j-ebr.2021370072
AMA derebey m,tarım i,Karabacak U,Şeker K,Özbalcı G Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. Experimental Biomedical Research. 2021; 4(3): 181 - 189. 10.30714/j-ebr.2021370072
Vancouver derebey m,tarım i,Karabacak U,Şeker K,Özbalcı G Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients. Experimental Biomedical Research. 2021; 4(3): 181 - 189. 10.30714/j-ebr.2021370072
IEEE derebey m,tarım i,Karabacak U,Şeker K,Özbalcı G "Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients." Experimental Biomedical Research, 4, ss.181 - 189, 2021. 10.30714/j-ebr.2021370072
ISNAD derebey, murat vd. "Fournier's gangrene: etiology, treatment outcomes and factors affecting mortality in 38patients". Experimental Biomedical Research 4/3 (2021), 181-189. https://doi.org/10.30714/j-ebr.2021370072